Author

Lisa M. Bloudek

Observed names: Bloudek, Lisa, Dr Lisa Bloudek, L Bloudek, L. Bloudek, L. M. Bloudek, L.M. Bloudek, Lisa Bloudek, Lisa M Bloudek

Institution: University of Washington

Observed institutions: Tufts University, Tufts Medical Center, University of Washington, Institute for Clinical and Economic Review, Allergan (United States)

OpenAlex ID: A5109959200

Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study ( IBMS‐II )

2013 · Andrew M. Blumenfeld, Lisa M. Bloudek, et al. · Headache The Journal of Head and Face Pain · 388

Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)

2012 · L. M. Bloudek, M. Stokes, et al. · The Journal of Headache and Pain · 344

PDF

Systematic Review of Migraine Prophylaxis Adherence and Persistence

2014 · Zsolt Hepp, Lisa M. Bloudek, et al. · Journal of Managed Care Pharmacy · 337

PDF

Review and Meta-Analysis of Biomarkers and Diagnostic Imaging in Alzheimer's Disease

2011 · Lisa M. Bloudek, D. Eldon Spackman, et al. · Journal of Alzheimer s Disease · 292

Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine

2014 · Regina Rendas-Baum, Min Yang, et al. · Health and Quality of Life Outcomes · 166

PDF

The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients

2012 · Regina Rendas-Baum, Lisa M. Bloudek, et al. · Quality of Life Research · 122

PDF

Adherence with Migraine Prophylaxis in Clinical Practice

2012 · Ariel Berger, Lisa M. Bloudek, et al. · Pain Practice · 115

PDF

HER2 expression in urothelial carcinoma, a systematic literature review

2022 · Emilie Scherrer, Ashley Kang, et al. · Frontiers in Oncology · 76

PDF

The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK

2013 · Anthony J. Batty, Ryan N. Hansen, et al. · Journal of Medical Economics · 66

PDF

Estimating the Costs of Therapy in Patients with Relapsed and/or Refractory Multiple Myeloma: A Model Framework.

2015 · Anuja Roy, Jonathan K Kish, et al. · PubMed · 61

Treatment Persistence and Switching in Triptan Users: A Systematic Literature Review

2014 · Andrew J. Messali, Mo Yang, et al. · Headache The Journal of Head and Face Pain · 49

Real‐World Economic Impact of Onabotulinumtoxin A in Patients With Chronic Migraine

2014 · John F. Rothrock, Lisa M. Bloudek, et al. · Headache The Journal of Head and Face Pain · 47

PDF

2013 · Joanna C Sanderson, Emily B Devine, et al. · Journal of Neurology Neurosurgery & Psychiatry · 47

PDF

Systematic literature review and meta-analysis of HER2 amplification, overexpression, and positivity in colorectal cancer

2023 · Harshabad Singh, Ashley Kang, et al. · JNCI Cancer Spectrum · 27

PDF

Trends in treatment patterns and costs of care among patients with advanced stage cervical cancer

2022 · Fernanda B. Musa, Elizabeth Brouwer, et al. · Gynecologic Oncology · 16

Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC)

2023 · Lisa Bloudek, Phoebe Wright, et al. · Current Oncology · 12

PDF

Total healthcare cost savings through improved bipolar I disorder identification using the Rapid Mood Screener in patients diagnosed with major depressive disorder

2023 · Roger S. McIntyre, Lisa Bloudek, et al. · Current Medical Research and Opinion · 11

PDF

Value-Based Pricing of US Prescription Drugs

2022 · Kai Yeung, Lisa Bloudek, et al. · JAMA Health Forum · 11

PDF

Are Drugs Priced in Accordance With Value? A Comparison of Value-Based and Net Prices Using Institute for Clinical and Economic Review Reports

2021 · Lisa M. Bloudek, Victor Nguyen, et al. · Value in Health · 11

Cost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US

2018 · Krithika Rajagopalan, Lisa Bloudek, et al. · International Journal of COPD · 11

PDF

Health Care Resource Utilization Following Initiation of a Triptan: A Retrospective Claims Analysis

2014 · Andrew Messali, Gary Owens, et al. · Journal of Managed Care Pharmacy · 11

PDF

Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies

2022 · Lisa Bloudek, Lawrence F. Eichenfield, et al. · American Journal of Clinical Dermatology · 10

PDF

Realized and Projected Cost-Savings from the Introduction of Generic Imatinib Through Formulary Management in Patients with Chronic Myelogenous Leukemia.

2019 · David Campbell, Marlo Blazer, et al. · Europe PMC (PubMed Central) · 10

The Effectiveness and Value of Siponimod for Secondary Progressive Multiple Sclerosis

2020 · Patricia G. Synnott, Lisa M. Bloudek, et al. · Journal of Managed Care & Specialty Pharmacy · 9

PDF

Estimating the Economic Impact of Adding Panobinostat to a U.S. Formulary for Relapsed and/or Refractory Multiple Myeloma: A Budget Impact and Cost-Benefit Model

2016 · Lisa Bloudek, Anuja Roy, et al. · Journal of Managed Care & Specialty Pharmacy · 9

PDF

Works count: 82

Citation count: 2,363

H-index: 15

I10-index: 23